Rosa Caputo
- Oncology top 2%
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer-related Molecular Pathways 2
- Cancer Research top 5%
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer 5
- Genetics top 10%
-
- Inflammatory mediators and NSAID effects 5
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Giampaolo TortoraFortunato CiardielloVincenzo DamianoRoberto BiancoA R BiancoSabino De PlacidoGabriella FontaniniTeresa Troiani
- Journals
- Clinical Cancer Research (5 papers)International Journal of Cancer (4 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Rosa Caputo
21 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 906
- Cancer Research 355
- Molecular Biology 1.0k
- Genetics 135
Countries citing papers authored by Rosa Caputo
This map shows the geographic impact of Rosa Caputo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Caputo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Caputo more than expected).
Fields of papers citing papers by Rosa Caputo
This network shows the impact of papers produced by Rosa Caputo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Caputo. The network helps show where Rosa Caputo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rosa Caputo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 25 | |
| 2 | 2007 | 51 | |
| 3 | 2006 | 65 | |
| 4 | 2005 | 32 | |
| 5 | 2005 | 70 | |
| 6 | Structure-activity relationship, physicochemical and pharmacokinetic properties of AZD2171: A highly potent inhibitor of VEGF receptor tyrosine kinases | 2004 | 9 |
| 7 | 2004 | 40 | |
| 8 | Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 2003 | 134 |
| 9 | Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity. | 2003 | 45 |
| 10 | Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. | 2003 | 286 |
| 11 | Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. | 2003 | 72 |
| 12 | 2002 | 79 | |
| 13 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). | 2002 | 205 |
| 14 | 2001 | 59 | |
| 15 | Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.breakdown → | 2001 | 531 |
| 16 | 2000 | 56 | |
| 17 | 2000 | 45 | |
| 18 | 2000 | 51 | |
| 19 | 1998 | 69 | |
| 20 | 1997 | 54 |
About Rosa Caputo
Rosa Caputo is a scholar working on Oncology, Pharmacology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Molecular Biology, having authored 21 papers that have together received 2.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (7 papers), Inflammatory mediators and NSAID effects (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (906 citations), Cancer Research (355 citations), Molecular Biology (1.0k citations) and Genetics (135 citations). Rosa Caputo has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giampaolo Tortora, Fortunato Ciardiello, Vincenzo Damiano, Roberto Bianco, A R Bianco, Sabino De Placido, Gabriella Fontanini, Teresa Troiani, Roberta Caputo and Bianca Maria Veneziani. Their work appears in journals such as Clinical Cancer Research, International Journal of Cancer, Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.